Literature DB >> 25532518

Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential.

Tao Liu1, Ji Feng Liu2, Hua Yu1, Guo Jing Si1, Jun Hu1, Jun Li1.   

Abstract

INTRODUCTION: Herpes simplex virus type 2 (HSV-2) is the most common cause of genital herpes. Glycoprotein G (gG) is a prototype antigen for type-specific serodiagnosis distinguishing between HSV type 1 (HSV-1) and HSV-2 infections. As immunological diagnosis kits for accurate differentiation between HSV-1 and HSV-2 antibodies can be expensive, there is a need to develop a convenient, sensitive, specific and cost-effective serodiagnostic kit.
METHODS: We successfully expressed a fragment of gG comprising residues 321-580 of HSV-2 with histidine tag (gG(321-580His)) in a Bac-to-Bac baculovirus expression system, which had an antigenicity similar to its native counterpart. An indirect enzyme-linked immunosorbent assay (ELISA) was developed using gG(321-580His) as the diagnostic antigen and evaluated by comparison with a commercial HerpeSelect 2 ELISA immunoglobulin G kit as reference.
RESULTS: In testing 318 field serum samples, the diagnostic relative sensitivity and specificity of the developed gG(321-580His)-ELISA test in qualitative comparison with the commercial kit were 93.81% and 96.74%, respectively, and the accuracy was 94.65%.
CONCLUSION: The study indicates that gG(321-580His) has a high diagnostic potential for HSV-2 virus serodiagnosis in humans.

Entities:  

Keywords:  baculovirus expression system; glycoprotein G; herpes simplex virus type 2; immunodominant fragment; indirect enzyme-linked immunosorbent assay

Mesh:

Substances:

Year:  2015        PMID: 25532518      PMCID: PMC4469854          DOI: 10.11622/smedj.2014197

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  30 in total

1.  Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2.

Authors:  D S Schmid; D R Brown; R Nisenbaum; R L Burke; D Alexander; R Ashley; P E Pellett; W C Reeves
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

2.  Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies.

Authors:  R L Ashley; L Wu; J W Pickering; M C Tu; L Schnorenberg
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

3.  ELISA. Theory and practice.

Authors:  J R Crowther
Journal:  Methods Mol Biol       Date:  1995

4.  The use of peptides from glycoproteins G-2 and D-1 for detecting herpes simplex virus type 2 and type-common antibodies.

Authors:  M Levi; U Rudén; H Carlberg; B Wahren
Journal:  J Clin Virol       Date:  1999-05       Impact factor: 3.168

5.  The genome sequence of herpes simplex virus type 2.

Authors:  A Dolan; F E Jamieson; C Cunningham; B C Barnett; D J McGeoch
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  The acquisition of herpes simplex virus during pregnancy.

Authors:  Z A Brown; S Selke; J Zeh; J Kopelman; A Maslow; R L Ashley; D H Watts; S Berry; M Herd; L Corey
Journal:  N Engl J Med       Date:  1997-08-21       Impact factor: 91.245

7.  Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype-specific diagnosis.

Authors:  H S Marsden; K MacAulay; J Murray; I W Smith
Journal:  J Med Virol       Date:  1998-09       Impact factor: 2.327

Review 8.  Standardisation and validation of enzyme-linked immunosorbent assay techniques for the detection of antibody in infectious disease diagnosis.

Authors:  P F Wright; E Nilsson; E M Van Rooij; M Lelenta; M H Jeggo
Journal:  Rev Sci Tech       Date:  1993-06       Impact factor: 1.181

9.  Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli.

Authors:  V A Luckow; S C Lee; G F Barry; P O Olins
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.

Authors:  A Wald; J Zeh; G Barnum; L G Davis; L Corey
Journal:  Ann Intern Med       Date:  1996-01-01       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.